Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
Authors not listed
ECOG-ACRIN Cancer Research Group · 2026
Abstract
This phase III trial compares the effect of wide local excision (WLE) alone to usual care with WLE plus sentinel lymph node (SLN) biopsy for the treatment of older adults with early-stage melanoma. A WLE is a surgical procedure performed to cut out an abnormal lesion and some surrounding normal tissue. This is sometimes followed by a SLN biopsy, in which lymph nodes that tumor cells could spread to are removed as well. Using WLE alone may be just as effective as usual care in treating older adults with early-stage melanoma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (2026). A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients. <em>ECOG-ACRIN Cancer Research Group</em>. https://clinicaltrials.gov/study/NCT07068074
Vancouver
Anonymous. A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients. ECOG-ACRIN Cancer Research Group. 2026.
BibTeX
@misc{anon2026ARando,
title = {A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients},
author = {Anonymous},
journal = {ECOG-ACRIN Cancer Research Group},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pusan National University Yangsan Hospital 2021
Open access · US-GOV
Effect of Silkworms (Bombyx Mori L.) Pupae Extracts on Musculoskeletal Biomarkers in Adults With With Relatively Low Muscle Mass: a Randomized, Double-blinded, Placebo-controlled Trial
Fondazione EMN Italy Onlus 2014
Open access · US-GOV
A PHASE III, MULTICENTRE, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
Hoffmann-La Roche 2021
Open access · US-GOV
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion
Regeneron Pharmaceuticals 2013
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Jiangsu Rec-Biotechnology Co., Ltd. 2022
Open access · US-GOV
A Multicenter, Randomized, Double-blinded, Placebo-controlled Phase III Trial to Evaluate the Efficacy, Safety and Immunogenicity of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older
WestVac Biopharma Co., Ltd. 2021
Open access · US-GOV